ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀå : ÄÄÆ÷³ÍÆ®º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Clinical Risk Grouping Solution Market, By Component, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå
:
1605781
¸®¼Ä¡»ç
:
AnalystView Market Insights
¹ßÇàÀÏ
:
2024³â 11¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 269 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¸®Æ÷Æ® ÇÏÀ̶óÀÌÆ®
ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀåÀº 2023³â¿¡ 7¾ï 490¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024-2032³â 14.10%ÀÇ CAGR·Î È®´ëÇß½À´Ï´Ù.
ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀå - ½ÃÀå ¿ªÇÐ
È¿À²ÀûÀÎ Áý´Ü °Ç°°ü¸®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ÀüÀڰǰ±â·Ï(EHR) Ȱ¿ë È®´ë°¡ ¸Â¹°·Á ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Áý´Ü°Ç°°ü¸®(PHM)´Â ´Ù¾çÇÑ °Ç° °áÁ¤ ¿äÀÎÀ» ÇØ°áÇÏ¿© °³ÀÎ Áý´ÜÀÇ °Ç° °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ÃÊÁ¡À» ¸ÂÃß°í ÀÖÀ¸¸ç, EHR ½Ã½ºÅÛÀÇ º¸±ÞÀ¸·Î ȯÀÚ µ¥ÀÌÅͰ¡ Áß¾Ó ÁýÁßÈµÇ¾î ½±°Ô Á¢±ÙÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÓ»ó À§Çè ±×·çÇÎ ¼Ö·ç¼ÇÀº ÀÌ µ¥ÀÌÅ͸¦ Ȱ¿ëÇÏ¿© ȯÀÚÀÇ À§ÇèÀ» Á¾ÇÕÀûÀ¸·Î Æò°¡Çϰí ÀÇ·áÁøÀÌ È¿°úÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ È®º¸ÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ¹Ì±¹º´¿øÇùȸ¿¡ µû¸£¸é 2021³â ÇöÀç ÀÇ»ç 5¸í Áß 4¸í(78%), ºñ¿¬¹æ ±Þ¼º±â º´¿øÀÇ °ÅÀÇ ¸ðµç º´¿ø(96%)ÀÌ ÀÎÁõµÈ EHRÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÅÈï ±¹°¡¿¡¼´Â ÀÇ·á ¼ºñ½º¸¦ °³¼±Çϱâ À§ÇØ µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀ» µµÀÔÇϰí ÀÖÀ¸¸ç, ÀÌ´Â Å« ½ÃÀå ±âȸ¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. ±×·¯³ª µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹× º¸¾È¿¡ ´ëÇÑ ¿ì·Á´Â ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.
ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®
´ç»çÀÇ ¸®¼Ä¡ ¾Ö³Î¸®½ºÆ®°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¸Å³â ¾à 14.10%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÄÄÆ÷³ÍÆ®º°·Î´Â ¼ÒÇÁÆ®¿þ¾î°¡ 2023³â¿¡ °¡Àå ³ôÀº ½ÃÀå Á¡À¯À²À» º¸¿´½À´Ï´Ù.
¿ëµµº°·Î´Â Æ÷ǽ·¹ÀÌ¼Ç °Ç°°ü¸®°¡ 2023³â ÁÖ¿ä ÄÄÆ÷³ÍÆ®·Î ²ÅÇû½À´Ï´Ù.
ÃÖÁ¾»ç¿ëÀÚº°·Î´Â 2023³â º´¿ø ¹× Ŭ¸®´Ð ºÎ¹®ÀÌ ÁÖ¿ä ÄÄÆ÷³ÍÆ®¿´½À´Ï´Ù.
Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ÁÖ¿ä ¼öÀÔ¿øÀ¸·Î ²ÅÇû½À´Ï´Ù.
ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀå - ¼¼ºÐÈ ºÐ¼® :
¼¼°è ÀÓ»ó À§Çè ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀåÀº ÄÄÆ÷³ÍÆ®, ¾ÖÇø®ÄÉÀ̼Ç, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ªÀ» ±âÁØÀ¸·Î ¼¼ºÐȵ˴ϴÙ.
½ÃÀåÀº ÄÄÆ÷³ÍÆ®¿¡ µû¶ó ¼ÒÇÁÆ®¿þ¾î ¹× ¼ºñ½º·Î ±¸ºÐµË´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î ºÎ¹®ÀÌ ½ÃÀå¿¡¼ ¾ÐµµÀûÀÎ ÁöÀ§¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÓ»ó À§Çè ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀåÀº ÀÇ·á ±â°ü¿¡¼ ÀÓ»ó À§ÇèÀ» Æò°¡ÇÏ°í °ü¸®Çϱâ À§ÇÑ ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀÌ ÁÖ¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù.
½ÃÀåÀº ¿ëµµ¿¡ µû¶ó Áý´Ü°Ç°°ü¸®, ¸¸¼ºÁúȯ °ü¸®, ÀÓ»ó ÀÇ»ç°áÁ¤ Áö¿ø, ºÎÁ¤ÇàÀ§ °¨Áö ¹× ¿¹¹æ, ±âŸ·Î ºÐ·ùµË´Ï´Ù. Áý´Ü°Ç°°ü¸®´Â ½ÃÀåÀÇ ÁÖ¿ä ºÎ¹®ÀÔ´Ï´Ù. ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ȯÀÚ Ä¡·á¸¦ °³¼±Çϰí Àα¸ °Ç° »óŸ¦ È¿°úÀûÀ¸·Î °ü¸®Çϱâ À§ÇØ ³ë·ÂÇÔ¿¡ µû¶ó ÀÓ»ó À§Çè ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀåÀº Áý´Ü°Ç°°ü¸®¿Í ¹ÐÁ¢ÇÏ°Ô ¿¬°üµÇ¾î ÀÖ½À´Ï´Ù.
½ÃÀåÀº ÃÖÁ¾»ç¿ëÀÚº°·Î º´¿ø ¹× Ŭ¸®´Ð, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), Àå±â ¿ä¾ç ¼¾ÅÍ, ±âŸ·Î ºÐ·ùµË´Ï´Ù. º´¿ø ¹× Ŭ¸®´Ð ºÐ¾ß´Â ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. ÀÌ ºÐ¾ß´Â È¿°úÀûÀÎ À§Çè Æò°¡ ¹× °ü¸®¸¦ ÅëÇØ ȯÀÚ ¾ÈÀüÀ» °³¼±Çϰí ÀÓ»ó Ä¡·á¸¦ ÃÖÀûÈÇÏ´Â µ¥ ÁßÁ¡À» µÎ°í ÀÖÀ¸¹Ç·Î È®ÀåÀ» °æÇèÇϰí ÀÖ½À´Ï´Ù.
ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀå - Áö¿ªÀû ÀλçÀÌÆ®
ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« µî Áö¿ªÀûÀ¸·Î ±¤¹üÀ§ÇÏ°Ô ºÐÆ÷µÇ¾î ÀÖ½À´Ï´Ù. À̵é Áö¿ªÀº »ç¾÷ Ȱµ¿¿¡ ±â¿©ÇÏ´Â ±¹°¡¿¡ µû¶ó ´õ ¼¼ºÐȵ˴ϴÙ. ºÏ¹Ì´Â ÁÖ·Î ÇコÄɾî IT ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡·Î ÀÎÇØ ½ÃÀå È®´ë¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ Á¤ºÎ´Â ÀÇ·á IT ½Ã½ºÅÛ °³¼±À» À§ÇÑ ¿©·¯ ±¸»óÀ» ½ÃÇàÇϰí ÀÖÀ¸¸ç, ±× Áß HITECH Act´Â ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ÀüÀڰǰ±â·Ï(EHR) ¹× ±âŸ ÀÇ·á IT ¼Ö·ç¼ÇÀ» µµÀÔÇϵµ·Ï Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÁýÁßÀûÀÎ ³ë·ÂÀº ÀÓ»ó À§Çè ±×·çÇÎ ¼Ö·ç¼Ç°ú °°Àº ÷´Ü ±â¼ú¿¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ·Î À̾îÁö°í ÀÖÀ¸¸ç, 2021³â ¹Ì±¹Àº ±¹³»ÃÑ»ý»ê(GDP)ÀÇ 17.8%¸¦ ÇコÄɾ ÇÒ´çÇÏ¿© OECD ±¹°¡ Æò±Õ ÁöÃâÀÇ °ÅÀÇ µÎ ¹è¿¡ ´ÞÇÏ´Â ÁöÃâÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´Àº ¸¸¼ºÁúȯ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ½ÃÀå ¼ºÀå·üÀÌ µÎ ¹øÂ°·Î ³ôÀº Áö¿ªÀÔ´Ï´Ù.
ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀå - °æÀï ±¸µµ:
ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀåÀº °æÀïÀÌ Ä¡¿ÇØÁö°í ÀÖÀ¸¸ç, ¸¹Àº ¾÷üµéÀÌ ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õÀÇ ¿ä±¸»çÇ׿¡ ¸Â´Â ÃÖ÷´Ü ¼Ö·ç¼ÇÀ» Á¦°øÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. °¢ ¾÷üµéÀº ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼ÇÀÇ ¿¹Ãø ±â´ÉÀ» Çâ»ó½Ã۱â À§ÇØ ÀΰøÁö´É, ¸Ó½Å·¯´×°ú °°Àº ÷´Ü ±â¼ú¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÇコÄɾî ȯ°æÀÌ °è¼Ó º¯ÈÇÏ´Â °¡¿îµ¥, Çõ½Å, »óÈ£¿î¿ë¼º, ±ÔÁ¦ »óȲÀ» Áß½ÃÇÏ°í º´¿ø ¹× Ŭ¸®´ÐÀÇ ¿ä±¸¿¡ È¿°úÀûÀ¸·Î ´ëÀÀÇÏ´Â ±â¾÷ÀÌ ¼º°øÇÒ ¼ö ÀÖ´Â ÃÖÀûÀÇ À§Ä¡¸¦ È®º¸ÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀå °³¿ä
Á¦2Àå °³¿ä
Á¦3Àå ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼ÇÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
½ÃÀå ±âȸ
½ÃÀåÀÇ ÇâÈÄ µ¿Çâ
Á¦4Àå ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼Ç ¾÷°è Á¶»ç
PEST ºÐ¼®
Porter's Five Forces ºÐ¼®
¼ºÀå Àü¸Á ÁöµµÁ¦ÀÛ
±ÔÁ¦ ±¸Á¶ ºÐ¼®
Á¦5Àå ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®
COVID-19 ÀÌÀüÀÇ ¿µÇ⠺м®
COVID-19 ÀÌÈÄÀÇ ¿µÇ⠺м®
Á¦6Àå ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀå ±¸µµ
ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
ÁÖ¿ä Á¦Á¶¾÷üº° ³»¿ª µ¥ÀÌÅÍ
±âÁ¸ ±â¾÷ÀÇ ºÐ¼®
½Å±Ô ±â¾÷ÀÇ ºÐ¼®
Á¦7Àå ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀå - ÄÄÆ÷³ÍÆ®º°
°³¿ä
ºÎ¹® Á¡À¯À² ºÐ¼® - ÄÄÆ÷³ÍÆ®º°
¼ÒÇÁÆ®¿þ¾î
ÇÁ¶óÀ̺ø Ŭ¶ó¿ìµå
ÆÛºí¸¯ Ŭ¶ó¿ìµå
ÇÏÀ̺긮µå Ŭ¶ó¿ìµå
¼ºñ½º
Á¦8Àå ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀå - ¿ëµµº°
°³¿ä
ºÎ¹® Á¡À¯À² ºÐ¼® - ¿ëµµº°
Àα¸ Çコ °ü¸®
¸¸¼ºÁúȯ °ü¸®
ÀÓ»ó ÀÇ»ç°áÁ¤ Áö¿ø
ºÎÁ¤ÇàÀ§ ŽÁö¿Í ¹æÁö
±âŸ
Á¦9Àå ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀå - ÃÖÁ¾»ç¿ëÀÚº°
°³¿ä
ºÎ¹® Á¡À¯À² ºÐ¼® - ÃÖÁ¾»ç¿ëÀÚº°
º´¿ø¡¤Áø·á¼Ò
¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
Àå±â ÄÉ¾î ¼¾ÅÍ
±âŸ
Á¦10Àå ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼Ç ½ÃÀå - Áö¿ªº°
¼·Ð
ºÏ¹Ì
°³¿ä
ºÏ¹ÌÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
¹Ì±¹
ij³ª´Ù
À¯·´
°³¿ä
À¯·´ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
µ¶ÀÏ
ÀÌÅ»¸®¾Æ
¿µ±¹
ÇÁ¶û½º
·¯½Ã¾Æ
³×´ú¶õµå
½º¿þµ§
Æú¶õµå
±âŸ
¾Æ½Ã¾ÆÅÂÆò¾ç
°³¿ä
¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
Àεµ
Áß±¹
ÀϺ»
Çѱ¹
È£ÁÖ
ű¹
Àεµ³×½Ã¾Æ
Çʸ®ÇÉ
±âŸ
¶óƾ¾Æ¸Þ¸®Ä«
°³¿ä
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
ºê¶óÁú
¸ß½ÃÄÚ
¾Æ¸£ÇîÆ¼³ª
ÄÝ·Òºñ¾Æ
±âŸ
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
°³¿ä
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
»ç¿ìµð¾Æ¶óºñ¾Æ
¾Æ¶ø¿¡¹Ì¸®Æ®
À̽º¶ó¿¤
ÅÍŰ
¾ËÁ¦¸®
ÀÌÁýÆ®
±âŸ
Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - ÀÓ»ó ¸®½ºÅ© ±×·çÇÎ ¼Ö·ç¼Ç ¾÷°è
°æÀï ´ë½Ãº¸µå
±â¾÷ °³¿ä
3M Corporation
4S Dawn Clinical Software
Apixio
Cotiviti Inc.
Evolent
HBI Solutions
Health Catalyst, Inc.
HealthEC LLC
Lightbeam Health Solutions
MedeAnalytics, Inc.
Nuance Communications, Inc.
Optum, Inc.
RELX(LexisNexis Risk Solution)
ZeOmega
±âŸ
Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á
KSA
¿µ¹® ¸ñÂ÷
REPORT HIGHLIGHT
The Clinical Risk Grouping Solution Market was valued at USD 704.90 million in 2023 and expanded at a CAGR of 14.10% from 2024 to 2032.
A Clinical Risk Grouping Solution represents a structured methodology employed in the healthcare sector to classify patients according to their clinical risks and requirements. This approach assists healthcare professionals in stratifying patients, thereby improving management, resource distribution, and the overall delivery of care. Such solutions are frequently utilized across diverse healthcare environments, including hospitals, managed care organizations, and public health programs, to optimize patient care and enhance operational effectiveness.
Clinical Risk Grouping Solution Market- Market Dynamics
The increasing need for efficient population health management, coupled with the expanding utilization of electronic health records (EHR), is anticipated to propel market growth.
Population health management (PHM) focuses on improving the health outcomes of groups of individuals by addressing various health determinants. The widespread adoption of EHR systems has resulted in centralized and accessible patient data. Clinical Risk Grouping Solutions leverage this data to conduct comprehensive assessments of patient risks, ensuring that healthcare providers have the information needed for effective decision-making. According to the American Hospital Association, as of 2021, nearly 4 in 5 office-based physicians (78%) and nearly all non-federal acute care hospitals (96%) adopted a certified EHR. Furthermore, Emerging economies are increasingly adopting digital health solutions to improve healthcare delivery, which presents significant market opportunities. However, Data Privacy and Security Concerns may hampers the market growth.
Clinical Risk Grouping Solution Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.10% over the forecast period (2024-2032)
Based on Component segmentation, software was predicted to show maximum market share in the year 2023
Based on Application segmentation, Population Health Management was the leading Component in 2023
Based on End-User segmentation, Hospitals, and clinics sector was the leading Component in 2023
Based on region, North America was the leading revenue generator in 2023
Clinical Risk Grouping Solution Market- Segmentation Analysis:
The Global Clinical Risk Grouping Solution Market is segmented based on Component, Application, End-User, and Region.
The market is segmented into three categories according to components: software and services. The software segment holds a dominant position in the market. The Clinical Risk Grouping Solution market is centered on software solutions aimed at evaluating and managing clinical risk within healthcare organizations.
The market is categorized into two segments based on application: Population Health Management, Chronic Disease Management, Clinical Decision Support, Fraud Detection and Prevention, and Others. Population Health Management is the leading segment within the market. The Clinical Risk Grouping Solution market is progressively aligning with Population Health Management as healthcare providers aim to improve patient care and effectively manage population health.
The market is classified into two primary categories according to End-User: Hospitals and clinics, Ambulatory surgical centers, Long-term care centers, and others. The Hospitals and clinics sector is the primary driver of market growth. This sector is experiencing expansion as it emphasizes improving patient safety and optimizing clinical care through effective risk assessment and management.
Clinical Risk Grouping Solution Market- Geographical Insights
This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These areas are further segmented based on the countries contributing to business activities. North America leads in market expansion, primarily due to increased investments in healthcare IT infrastructure. The U.S. government has implemented several initiatives to improve healthcare IT systems, including the HITECH Act, which encourages healthcare providers to adopt electronic health records (EHRs) and other health IT solutions. This emphasis has resulted in substantial investments in advanced technologies, such as Clinical Risk Grouping Solutions. In 2021, the United States allocated 17.8 percent of its gross domestic product (GDP) to healthcare, nearly double the average expenditure of OECD countries. Europe ranks as the second largest region for market growth, driven by a rising awareness of chronic diseases.
Clinical Risk Grouping Solution Market- Competitive Landscape:
The market for Clinical Risk Grouping Solutions is becoming progressively competitive, with a multitude of participants aiming to deliver cutting-edge solutions tailored to the requirements of healthcare providers. Organizations are making significant investments in advanced technologies, including artificial intelligence and machine learning, to improve the predictive functionalities of their risk grouping offerings. Such innovation is essential for sustaining a competitive edge. As the healthcare landscape continues to transform, those companies that emphasize innovation, interoperability, and regulatory compliance while effectively addressing the demands of hospitals and clinics will be optimally positioned for success.
Recent Developments:
On April 1, 2021, 3M Health Information Systems launched an innovative technology platform designed to enable healthcare providers and payers to focus on care prioritization and resource allocation for individuals and patient groups identified as high-risk.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
3M Corporation
4S Dawn Clinical Software
Apixio
Cotiviti Inc.
Evolent
HBI Solutions
Health Catalyst, Inc.
HealthEC LLC
Lightbeam Health Solutions
MedeAnalytics, Inc.
Nuance Communications, Inc.
Optum, Inc.
RELX (LexisNexis Risk Solution)
ZeOmega
Others
GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032
Software
Private Cloud
Public Cloud
Hybrid Cloud
Services
GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Population health management
Chronic disease management
Clinical decision support
Fraud detection and prevention
Other
GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
Hospitals & clinics
Ambulatory surgical centers
Long-term care centers
Other
GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
Table of Contents
1. Clinical Risk Grouping Solution Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Clinical Risk Grouping Solution Market Snippet by Component
2.1.2. Clinical Risk Grouping Solution Market Snippet by Application
2.1.3. Clinical Risk Grouping Solution Market Snippet by End-User
2.1.4. Clinical Risk Grouping Solution Market Snippet by Country
2.1.5. Clinical Risk Grouping Solution Market Snippet by Region
2.2. Competitive Insights
3. Clinical Risk Grouping Solution Key Market Trends
3.1. Clinical Risk Grouping Solution Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Clinical Risk Grouping Solution Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Clinical Risk Grouping Solution Market Opportunities
3.4. Clinical Risk Grouping Solution Market Future Trends
4. Clinical Risk Grouping Solution Industry Study
4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Clinical Risk Grouping Solution Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Clinical Risk Grouping Solution Market Landscape
6.1. Clinical Risk Grouping Solution Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players' Analysis
6.2.2. Emerging Players' Analysis
7. Clinical Risk Grouping Solution Market - By Component
7.1. Overview
7.1.1. Segment Share Analysis, By Component, 2023 & 2032 (%)
7.1.2. Software
7.1.2.1. Private Cloud
7.1.2.2. Public Cloud
7.1.2.3. Hybrid Cloud
7.1.3. Services
8. Clinical Risk Grouping Solution Market - By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
8.1.2. Population health management
8.1.3. Chronic disease management
8.1.4. Clinical decision support
8.1.5. Fraud detection and prevention
8.1.6. Other
9. Clinical Risk Grouping Solution Market - By End-User
9.1. Overview
9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
9.1.2. Hospitals & clinics
9.1.3. Ambulatory surgical centers
9.1.4. Long term care centers
9.1.5. Other
10. Clinical Risk Grouping Solution Market- By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Clinical Risk Grouping Solution Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Clinical Risk Grouping Solution Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Clinical Risk Grouping Solution Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Clinical Risk Grouping Solution Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Clinical Risk Grouping Solution Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Clinical Risk Grouping Solution Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. 3M Corporation
11.2.2. 4S Dawn Clinical Software
11.2.3. Apixio
11.2.4. Cotiviti Inc.
11.2.5. Evolent
11.2.6. HBI Solutions
11.2.7. Health Catalyst, Inc.
11.2.8. HealthEC LLC
11.2.9. Lightbeam Health Solutions
11.2.10. MedeAnalytics, Inc.
11.2.11. Nuance Communications, Inc.
11.2.12. Optum, Inc.
11.2.13. RELX (LexisNexis Risk Solution)
11.2.14. ZeOmega
11.2.15. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
°ü·ÃÀÚ·á